• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索基因组测序在已确诊慢性肾脏病中的影响和效用。

Exploring the impact and utility of genomic sequencing in established CKD.

作者信息

Jefferis Julia, Mallett Andrew J

机构信息

Genetic Health Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia.

Faculty of Medicine, The University of Queensland, Brisbane, Australia.

出版信息

Clin Kidney J. 2024 Feb 21;17(3):sfae043. doi: 10.1093/ckj/sfae043. eCollection 2024 Mar.

DOI:10.1093/ckj/sfae043
PMID:38464959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10921391/
Abstract

Clinical genetics is increasingly recognized as an important area within nephrology care. Clinicians require awareness of genetic kidney disease to recognize clinical phenotypes, consider use of genomics to aid diagnosis, and inform treatment decisions. Understanding the broad spectrum of clinical phenotypes and principles of genomic sequencing is becoming increasingly required in clinical nephrology, with nephrologists requiring education and support to achieve meaningful patient outcomes. Establishment of effective clinical resources, multi-disciplinary teams and education is important to increase application of genomics in clinical care, for the benefit of patients and their families. Novel applications of genomics in chronic kidney disease include pharmacogenomics and clinical translation of polygenic risk scores. This review explores established and emerging impacts and utility of genomics in kidney disease.

摘要

临床遗传学在肾脏病护理领域日益被视为一个重要领域。临床医生需要了解遗传性肾脏疾病,以识别临床表型,考虑使用基因组学辅助诊断,并为治疗决策提供依据。在临床肾脏病学中,越来越需要了解广泛的临床表型和基因组测序原则,肾脏病医生需要接受教育和获得支持,以实现有意义的患者治疗效果。建立有效的临床资源、多学科团队和开展教育,对于增加基因组学在临床护理中的应用、造福患者及其家庭而言非常重要。基因组学在慢性肾脏病中的新应用包括药物基因组学和多基因风险评分的临床转化。本综述探讨了基因组学在肾脏疾病中既有的和新出现的影响及应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d4/10921391/747766ca5e50/sfae043fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d4/10921391/61015a29eb99/sfae043fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d4/10921391/960b937503f8/sfae043fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d4/10921391/747766ca5e50/sfae043fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d4/10921391/61015a29eb99/sfae043fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d4/10921391/960b937503f8/sfae043fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d4/10921391/747766ca5e50/sfae043fig3.jpg

相似文献

1
Exploring the impact and utility of genomic sequencing in established CKD.探索基因组测序在已确诊慢性肾脏病中的影响和效用。
Clin Kidney J. 2024 Feb 21;17(3):sfae043. doi: 10.1093/ckj/sfae043. eCollection 2024 Mar.
2
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future.哪些 CKD 患者将从基因组测序中受益?综合进展以展望未来。
Curr Opin Nephrol Hypertens. 2022 Nov 1;31(6):541-547. doi: 10.1097/MNH.0000000000000836. Epub 2022 Sep 7.
3
Clinical Pharmacogenomics: Applications in Nephrology.临床药物基因组学:在肾脏病学中的应用。
Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1561-1571. doi: 10.2215/CJN.02730218. Epub 2018 May 23.
4
A decision-making framework for genomic testing in paediatric nephrology.儿科肾脏病学中基因组检测的决策框架。
J Paediatr Child Health. 2023 Dec;59(12):1304-1310. doi: 10.1111/jpc.16514. Epub 2023 Nov 17.
5
Attitudes and Practices of Australian Nephrologists Toward Implementation of Clinical Genomics.澳大利亚肾脏病学家对临床基因组学实施的态度与实践
Kidney Int Rep. 2020 Nov 10;6(2):272-283. doi: 10.1016/j.ekir.2020.10.030. eCollection 2021 Feb.
6
Genomics in CKD: Is This the Path Forward?慢性肾脏病中的基因组学:这是前进的道路吗?
Adv Chronic Kidney Dis. 2016 Mar;23(2):120-4. doi: 10.1053/j.ackd.2016.01.017.
7
Genomics in nephrology: identifying informatics opportunities to improve diagnosis of genetic kidney disorders using a human-centered design approach.肾病学中的基因组学:使用以人为中心的设计方法识别信息学机会,以改善遗传肾脏疾病的诊断。
J Am Med Inform Assoc. 2024 May 20;31(6):1247-1257. doi: 10.1093/jamia/ocae053.
8
Pilot Study of Return of Genetic Results to Patients in Adult Nephrology.成人肾脏病患者遗传检测结果返还的初步研究。
Clin J Am Soc Nephrol. 2020 May 7;15(5):651-664. doi: 10.2215/CJN.12481019. Epub 2020 Apr 16.
9
Predicting outcomes in chronic kidney disease: needs and preferences of patients and nephrologists.预测慢性肾脏病的结局:患者和肾病学家的需求和偏好。
BMC Nephrol. 2023 Mar 22;24(1):66. doi: 10.1186/s12882-023-03115-3.
10
Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocol.对疑似遗传性肾脏疾病且接受临床基因组检测的澳大利亚前瞻性患者队列进行综合评估:研究方案。
BMJ Open. 2019 Aug 5;9(8):e029541. doi: 10.1136/bmjopen-2019-029541.

引用本文的文献

1
Emerging Biomarkers and Advanced Diagnostics in Chronic Kidney Disease: Early Detection Through Multi-Omics and AI.慢性肾脏病中的新兴生物标志物与先进诊断:通过多组学和人工智能实现早期检测
Diagnostics (Basel). 2025 May 13;15(10):1225. doi: 10.3390/diagnostics15101225.
2
Navigating Genetic Testing in Nephrology: Options and Decision-Making Strategies.肾内科中的基因检测导航:选择与决策策略
Kidney Int Rep. 2024 Dec 27;10(3):673-695. doi: 10.1016/j.ekir.2024.12.020. eCollection 2025 Mar.

本文引用的文献

1
Beyond the kidney biopsy: genomic approach to undetermined kidney diseases.超越肾活检:未明肾脏疾病的基因组学方法
Clin Kidney J. 2023 Apr 25;17(1):sfad099. doi: 10.1093/ckj/sfad099. eCollection 2024 Jan.
2
Polygenic risk alters the penetrance of monogenic kidney disease.多基因风险改变单基因肾脏疾病的外显率。
Nat Commun. 2023 Dec 14;14(1):8318. doi: 10.1038/s41467-023-43878-9.
3
Diagnosis of Kidney Diseases of Unknown Etiology Through Biopsy-Genetic Analysis.通过活检-基因分析诊断病因不明的肾脏疾病
Kidney Int Rep. 2023 Jul 22;8(10):2077-2087. doi: 10.1016/j.ekir.2023.07.003. eCollection 2023 Oct.
4
Determining the utility of diagnostic genomics: a conceptual framework.确定诊断基因组学的实用性:一个概念框架。
Hum Genomics. 2023 Aug 16;17(1):75. doi: 10.1186/s40246-023-00524-1.
5
Genomic testing for suspected monogenic kidney disease in children and adults: A health economic evaluation.儿童和成人疑似单基因肾脏疾病的基因组检测:健康经济学评价。
Genet Med. 2023 Nov;25(11):100942. doi: 10.1016/j.gim.2023.100942. Epub 2023 Jul 22.
6
Clinical utility of genetic testing in Indian children with kidney diseases.基因检测在印度肾脏病患儿中的临床应用
BMC Nephrol. 2023 Jul 18;24(1):212. doi: 10.1186/s12882-023-03240-z.
7
Atypical splicing variants in PKD1 explain most undiagnosed typical familial ADPKD.PKD1中的非典型剪接变体解释了大多数未确诊的典型家族性常染色体显性多囊肾病。
NPJ Genom Med. 2023 Jul 7;8(1):16. doi: 10.1038/s41525-023-00362-z.
8
The Effect of Genotyping on the Number of Pharmacotherapeutic Gene-Drug Interventions in Chronic Kidney Disease Patients.基因分型对慢性肾脏病患者药物治疗性基因-药物相互作用数量的影响
Pharmacy (Basel). 2023 Apr 4;11(2):69. doi: 10.3390/pharmacy11020069.
9
Alport syndrome misdiagnosed with IgA nephropathy from familial history: a case report and brief review.Alport 综合征误诊为家族史 IgA 肾病:病例报告并文献复习。
BMC Nephrol. 2023 Apr 15;24(1):97. doi: 10.1186/s12882-023-03165-7.
10
Molecular genetic diagnosis of kidney ciliopathies: Lessons from interpreting genomic sequencing data and the requirement for accurate phenotypic data.肾脏纤毛病的分子遗传学诊断:解读基因组测序数据的经验教训及对准确表型数据的要求。
Ann Hum Genet. 2024 Jan;88(1):76-85. doi: 10.1111/ahg.12508. Epub 2023 Apr 12.